165 related articles for article (PubMed ID: 26583878)
21. Benefits and harms of 4-factor prothrombin complex concentrate for reversal of vitamin K antagonist associated bleeding: a systematic review and meta-analysis.
Brekelmans MPA; Ginkel KV; Daams JG; Hutten BA; Middeldorp S; Coppens M
J Thromb Thrombolysis; 2017 Jul; 44(1):118-129. PubMed ID: 28540468
[TBL] [Abstract][Full Text] [Related]
22. Key concepts in the management of difficult hemorrhagic cases.
MacLaren R
Pharmacotherapy; 2007 Sep; 27(9 Pt 2):93S-102S. PubMed ID: 17723112
[TBL] [Abstract][Full Text] [Related]
23. The use of vitamin K in patients on anticoagulant therapy: a practical guide.
Hanslik T; Prinseau J
Am J Cardiovasc Drugs; 2004; 4(1):43-55. PubMed ID: 14967065
[TBL] [Abstract][Full Text] [Related]
24. [Prothrombin complex concentrate good in warfarin induced hemorrhage. Quick reversal--plasma should be avoided].
Själander A; Berntorp E; Svensson PJ
Lakartidningen; 2009 Sep 9-15; 106(37):2278, 2280-1. PubMed ID: 19817161
[No Abstract] [Full Text] [Related]
25. Rapid Warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate.
Woo CH; Patel N; Conell C; Rao VA; Faigeles BS; Patel MC; Pombra J; Akins PT; Axelrod YK; Ge IY; Sheridan WF; Flint AC
World Neurosurg; 2014 Jan; 81(1):110-5. PubMed ID: 23220122
[TBL] [Abstract][Full Text] [Related]
26. Reversal of vitamin K antagonists prior to urgent surgery.
Grobler C; Callum J; McCluskey SA
Can J Anaesth; 2010 May; 57(5):458-67. PubMed ID: 20077167
[TBL] [Abstract][Full Text] [Related]
27. Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion.
Aguilar MI; Hart RG; Kase CS; Freeman WD; Hoeben BJ; García RC; Ansell JE; Mayer SA; Norrving B; Rosand J; Steiner T; Wijdicks EF; Yamaguchi T; Yasaka M
Mayo Clin Proc; 2007 Jan; 82(1):82-92. PubMed ID: 17285789
[TBL] [Abstract][Full Text] [Related]
28. Four-factor prothrombin complex concentrate for urgent reversal of vitamin K antagonists in patients with major bleeding.
Quinlan DJ; Eikelboom JW; Weitz JI
Circulation; 2013 Sep; 128(11):1179-81. PubMed ID: 23935012
[No Abstract] [Full Text] [Related]
29. Correction of coagulopathy in warfarin associated cerebral hemorrhage.
Aiyagari V; Testai FD
Curr Opin Crit Care; 2009 Apr; 15(2):87-92. PubMed ID: 19300085
[TBL] [Abstract][Full Text] [Related]
30. Hemostatic therapy should not be used for acute treatment of anticoagulation-related intracerebral hemorrhage.
Stapf C
Stroke; 2012 Sep; 43(9):2537-8. PubMed ID: 22811461
[No Abstract] [Full Text] [Related]
31. Prevention of treatment-related fluid overload reduces estimated effective cost of prothrombin complex concentrate in patients requiring rapid vitamin K antagonist reversal.
Jones CA; Ducis K; Petrozzino J; Clark E; Fung MK; Peters C; Sarkar IN; Krol E; Pochal B; Boutrus A; Weimersheimer P; Freeman K
Expert Rev Pharmacoecon Outcomes Res; 2016; 16(1):135-9. PubMed ID: 26211539
[TBL] [Abstract][Full Text] [Related]
32. Clinical Applications of 4-Factor Prothrombin Complex Concentrate: A Practical Pathologist's Perspective.
Unold D; Tormey CA
Arch Pathol Lab Med; 2015 Dec; 139(12):1568-75. PubMed ID: 26619030
[TBL] [Abstract][Full Text] [Related]
33. Warfarin reversal in anticoagulant-associated intracerebral hemorrhage.
Goldstein JN; Rosand J; Schwamm LH
Neurocrit Care; 2008; 9(2):277-83. PubMed ID: 18214714
[TBL] [Abstract][Full Text] [Related]
34. Treatment of intracerebral hemorrhage associated with new oral anticoagulant use: the neurologist's view.
Veltkamp R; Horstmann S
Clin Lab Med; 2014 Sep; 34(3):587-94. PubMed ID: 25168944
[TBL] [Abstract][Full Text] [Related]
35. Hemostatic therapy in experimental intracerebral hemorrhage associated with rivaroxaban.
Zhou W; Zorn M; Nawroth P; Bütehorn U; Perzborn E; Heitmeier S; Veltkamp R
Stroke; 2013 Mar; 44(3):771-8. PubMed ID: 23339956
[TBL] [Abstract][Full Text] [Related]
36. The impact of the approval of prothrombin complex concentrates for vitamin K antagonist-related intracerebral hemorrhage: A retrospective study.
Watanabe S; Matsumoto S; Nakahara I; Morioka J; Hasebe A; Tanabe J; Suyama K; Ishihara T; Ohta T; Hatano T; Nagata I; Hirose Y
J Stroke Cerebrovasc Dis; 2022 Dec; 31(12):106861. PubMed ID: 36323169
[TBL] [Abstract][Full Text] [Related]
37. Reducing delays to administration of prothrombin complex concentrate in patients with vitamin K antagonist-related intracerebral haemorrhage.
Marrinan E; Chen L; Werring D; Turner D
Br J Hosp Med (Lond); 2020 Feb; 81(2):1-6. PubMed ID: 32097070
[TBL] [Abstract][Full Text] [Related]
38. Surgical treatment of spontaneous intracerebral hemorrhage in a full-term infant with coagulopathy--case report.
Yokoyama S; Takayama K; Murakami T; Ishikawa Y; Fujiwara N; Ganaha H
Neurol Med Chir (Tokyo); 2003 Feb; 43(2):85-7. PubMed ID: 12627886
[TBL] [Abstract][Full Text] [Related]
39. Superwarfarin ingestion treated successfully with prothrombin complex concentrate.
Haesloop O; Tillick A; Nichol G; Strote J
Am J Emerg Med; 2016 Jan; 34(1):116.e1-2. PubMed ID: 26070236
[TBL] [Abstract][Full Text] [Related]
40. PPSB as first choice treatment in the reversal of oral anticoagulant therapy.
Strengers PF; Drenth JC
Acta Anaesthesiol Belg; 2002; 53(3):183-6. PubMed ID: 12461827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
